Obrig TG - Search Results

1

Effect of TNF-alpha, Shiga toxin and calcium ionophore on Weibel-Palade body content of endothelial cells: possible implications for the hemolytic uremic syndrome.

Kaye SA, Obrig TG. Kaye SA, et al. Among authors: obrig tg. Thromb Res. 1995 Aug 15;79(4):415-21. doi: 10.1016/0049-3848(95)00130-j. Thromb Res. 1995. PMID: 7482445 No abstract available.

2

Shiga toxin pathogenesis: kidney complications and renal failure.

Obrig TG, Karpman D. Obrig TG, et al. Curr Top Microbiol Immunol. 2012;357:105-36. doi: 10.1007/82_2011_172. Curr Top Microbiol Immunol. 2012. PMID: 21983749 Free PMC article. Review.

3

Shiga toxin 2 targets the murine renal collecting duct epithelium.

Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, Mathieson PW, Obrig TG. Psotka MA, et al. Among authors: obrig tg. Infect Immun. 2009 Mar;77(3):959-69. doi: 10.1128/IAI.00679-08. Epub 2009 Jan 5. Infect Immun. 2009. PMID: 19124603 Free PMC article.

4

Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy.

Andreoli SP, Trachtman H, Acheson DW, Siegler RL, Obrig TG. Andreoli SP, et al. Among authors: obrig tg. Pediatr Nephrol. 2002 Apr;17(4):293-8. doi: 10.1007/s00467-001-0783-0. Pediatr Nephrol. 2002. PMID: 11956886 No abstract available.

5

Human platelet aggregation is not altered by Shiga toxins 1 or 2.

Viisoreanu D, Polanowska-Grabowska R, Suttitanamongkol S, Obrig TG, Gear AR. Viisoreanu D, et al. Among authors: obrig tg. Thromb Res. 2000 Jun 1;98(5):403-10. doi: 10.1016/s0049-3848(00)00191-2. Thromb Res. 2000. PMID: 10828480

6

The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis.

Obrig TG, Moran TP, Brown JE. Obrig TG, et al. Biochem J. 1987 Jun 1;244(2):287-94. doi: 10.1042/bj2440287. Biochem J. 1987. PMID: 3663122 Free PMC article.

7

Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.

Obrig TG, Del Vecchio PJ, Brown JE, Moran TP, Rowland BM, Judge TK, Rothman SW. Obrig TG, et al. Infect Immun. 1988 Sep;56(9):2373-8. doi: 10.1128/IAI.56.9.2373-2378.1988. Infect Immun. 1988. PMID: 3044997 Free PMC article.

8

Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.

Kaye SA, Louise CB, Boyd B, Lingwood CA, Obrig TG. Kaye SA, et al. Among authors: obrig tg. Infect Immun. 1993 Sep;61(9):3886-91. doi: 10.1128/IAI.61.9.3886-3891.1993. Infect Immun. 1993. PMID: 8359910 Free PMC article.

9

Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.

Louise CB, Obrig TG. Louise CB, et al. Among authors: obrig tg. Microvasc Res. 1994 May;47(3):377-87. doi: 10.1006/mvre.1994.1030. Microvasc Res. 1994. PMID: 8084301

10

Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.

Louise CB, Kaye SA, Boyd B, Lingwood CA, Obrig TG. Louise CB, et al. Among authors: obrig tg. Infect Immun. 1995 Jul;63(7):2766-9. doi: 10.1128/IAI.63.7.2766-2769.1995. Infect Immun. 1995. PMID: 7790096 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results